spacer
spacer

PDBsum entry 4zvp

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Hydrolase/hydrolase inhibitor PDB id
4zvp

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
139 a.a.
93 a.a.
Ligands
ACE-ASP-GLU-VAL-
ASA
×2
Waters ×76
PDB id:
4zvp
Name: Hydrolase/hydrolase inhibitor
Title: Caspase-7 variant 2 (v2) with reprogrammed substrate specificity due to y230v/w232m/q276c substitutions bound to devd inhibitor.
Structure: Caspase-7. Chain: a, c. Fragment: unp residues 34-231. Synonym: casp-7,apoptotic protease mch-3,cmh-1,ice-like apoptotic protease 3,ice-lap3. Engineered: yes. Caspase-7. Chain: b, d. Fragment: unp residues 232-336.
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: casp7, mch3. Expressed in: escherichia coli. Expression_system_taxid: 469008. Synthetic: yes. Synthetic construct. Organism_taxid: 32630
Resolution:
2.50Å     R-factor:   0.169     R-free:   0.224
Authors: M.E.Hill,D.J.Macpherson,J.A.Hardy
Key ref: M.E.Hill et al. (2016). Reprogramming Caspase-7 Specificity by Regio-Specific Mutations and Selection Provides Alternate Solutions for Substrate Recognition. Acs Chem Biol, 11, 1603-1612. PubMed id: 27032039 DOI: 10.1021/acschembio.5b00971
Date:
18-May-15     Release date:   20-Apr-16    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P55210  (CASP7_HUMAN) -  Caspase-7 from Homo sapiens
Seq:
Struc:
303 a.a.
139 a.a.
Protein chains
Pfam   ArchSchema ?
P55210  (CASP7_HUMAN) -  Caspase-7 from Homo sapiens
Seq:
Struc:
303 a.a.
93 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 3 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class: Chains A, B, C, D: E.C.3.4.22.60  - caspase-7.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

 

 
DOI no: 10.1021/acschembio.5b00971 Acs Chem Biol 11:1603-1612 (2016)
PubMed id: 27032039  
 
 
Reprogramming Caspase-7 Specificity by Regio-Specific Mutations and Selection Provides Alternate Solutions for Substrate Recognition.
M.E.Hill, D.J.MacPherson, P.Wu, O.Julien, J.A.Wells, J.A.Hardy.
 
  ABSTRACT  
 
The ability to routinely engineer protease specificity can allow us to better understand and modulate their biology for expanded therapeutic and industrial applications. Here, we report a new approach based on a caged green fluorescent protein (CA-GFP) reporter that allows for flow-cytometry-based selection in bacteria or other cell types enabling selection of intracellular protease specificity, regardless of the compositional complexity of the protease. Here, we apply this approach to introduce the specificity of caspase-6 into caspase-7, an intracellular cysteine protease important in cellular remodeling and cell death. We found that substitution of substrate-contacting residues from caspase-6 into caspase-7 was ineffective, yielding an inactive enzyme, whereas saturation mutagenesis at these positions and selection by directed evolution produced active caspases. The process produced a number of nonobvious mutations that enabled conversion of the caspase-7 specificity to match caspase-6. The structures of the evolved-specificity caspase-7 (esCasp-7) revealed alternate binding modes for the substrate, including reorganization of an active site loop. Profiling the entire human proteome of esCasp-7 by N-terminomics demonstrated that the global specificity toward natural protein substrates is remarkably similar to that of caspase-6. Because the esCasp-7 maintained the core of caspase-7, we were able to identify a caspase-6 substrate, lamin C, that we predict relies on an exosite for substrate recognition. These reprogrammed proteases may be the first tool built with the express intent of distinguishing exosite dependent or independent substrates. This approach to specificity reprogramming should also be generalizable across a wide range of proteases.
 

 

spacer

spacer